Table 4 Perioperative mortality and morbidity
From: Should bioprostheses be considered the valve of choice for dialysis-dependent patients?
Variable | Group B (n = 38) | Group M (n = 35) | P-value |
|---|---|---|---|
Hospital mortality (30-day) | 2(5.2%) | 2(5.7%) | NS |
Perioperative myocardial infarction | 3(7.9%) | 3(8.6%) | NS |
Respiratory failure | 2(5.2%) | 2(5.7%) | NS |
Pacemaker placement | 1(2.6%) | 1(2.9%) | NS |
Re-exploration for bleeding | 2(5.2%) | 2(5.7%) | NS |
Cerebral vascular accident | 1(2.6%) | 1(2.9%) | NS |
Sepsis | 1(2.6%) | 1(2.9%) | NS |
Deep sternal wound infection | 2(5.4%) | 2(5.7%) | NS |
Gastrointestinal complications | 1(2.6%) | 2(5.7%) | <0.05 |
Length of Intensive care unit stay (days) | 3.5 ± 1.0 | 3.6 ± 1.2 | NS |